Review of the safety and efficacy of risedronate for the treatment of male osteoporosis

about

Updates on mechanism of action and clinical efficacy of risedronate in osteoporosis Recommendations for Diagnosis and Management of Osteoporosis in COPD Men.

P2860

Q26864549-ADDBA051-1F77-47E5-AA4A-4793E1E05906 Q35687804-0C829533-62BB-4741-B3F2-11DF344E1DB6

P2860

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis

Item

http://www.wikidata.org/entity/Q37017415

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis

@en

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis.

@nl

type

Item

label

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis

@en

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis.

@nl

prefLabel

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis

@en

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis.

@nl

P1476

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis

@en

P2093

Jonathan D Adachi

http://www.w3.org/2001/XMLSchema#string

Raja Bobba

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

Osteoporosis and osteoporotic fractures in men: a clinical perspective.

Pharmacotherapy of osteoporosis in men.

Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos).

Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves' disease.

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Risedronate increases bone density and reduces vertebral fracture risk within one year in men on corticosteroid therapy.

Prevalence of low femoral bone density in older U.S. adults from NHANES III.

Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies.

The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits.

P304

275-282

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18044178

http://www.w3.org/2001/XMLSchema#string

P921

osteoporosis

organophosphorus compound

P932

2685258

http://www.w3.org/2001/XMLSchema#string

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis

about

P2860

P2860

Review of the safety and efficacy of risedronate for the treatment of male osteoporosis

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932

P1433

P1476

P2093

P2860

P304

P31

P407

P433

P478

P577

P698

P921

P932